While the impact of Covid-19 led to profound difficulties for many individuals and businesses, it also highlighted the importance of innovation and the value of innovative companies to society and the economy.
British Patient Capital establishes itself as a major player in UK venture and venture growth markets: Investing in 12 funds with £334m of new commitments in its first year
Unfortunately this site does not support your browser
This site may not display correctly in your current browser. To view the site in its intended form and for the best user experience, download the latest version of your browser using the options below.